COMPANY

Inhalon Biopharma

HQ: Carrboro, NC source · inhalon.com ↗ · Southeast

Stage (company-reported): Phase 1 · source · Oct 12, 2026

Keywords: antibody inhaled respiratory respiratory syncytial virus infectious disease influenza severe acute respiratory syndrome

Location: Carrboro, NC · source · Sep 17, 2020

Profile checked Oct 10, 2026

7NIH grants

Timeline

Sep 22, 2025 Grant Government contract: $3.18M (total, as published), announced Sep 22, 2025. Agency: DoD. Source: government award database. source ↗
Sep 2, 2025 Grant Government grant — SBIR: $1.01M (annual award, as published), announced Sep 2, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Aug 19, 2025 Grant Government grant — SBIR: $1.02M (annual award, as published), announced Aug 19, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Jul 30, 2025 Grant Government grant — SBIR: $1.01M (annual award, as published), announced Jul 30, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 11, 2025 Grant Government grant — SBIR: $608,832 (annual award, as published), announced Jun 11, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
May 8, 2025 Grant Government grant — SBIR: $1.02M (annual award, as published), announced May 8, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Apr 9, 2025 Grant Government grant — SBIR: $1.02M (annual award, as published), announced Apr 9, 2025. Agency: NIH/NIAID. Source: government award database. source ↗

Funding

Last 2 years.

Sep 22, 2025 Government contract: $3.18M (total, as published), announced Sep 22, 2025. Agency: DoD. Source: government award database. source ↗
Sep 2, 2025 Government grant — SBIR: $1.01M (annual award, as published), announced Sep 2, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Aug 19, 2025 Government grant — SBIR: $1.02M (annual award, as published), announced Aug 19, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Jul 30, 2025 Government grant — SBIR: $1.01M (annual award, as published), announced Jul 30, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 11, 2025 Government grant — SBIR: $608,832 (annual award, as published), announced Jun 11, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
May 8, 2025 Government grant — SBIR: $1.02M (annual award, as published), announced May 8, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Apr 9, 2025 Government grant — SBIR: $1.02M (annual award, as published), announced Apr 9, 2025. Agency: NIH/NIAID. Source: government award database. source ↗

NIH awards 7

Annual award amounts. Total $7.1M.

Jun 21, 2024 NIH award 1R44AI186834-01 FY2024: $1,024,926 awarded for that fiscal year; activity R44 (SBIR); PI HUTCHINS, JEFF T; recipient as written: INHALON BIOPHARMA, INC., Morrisville, NC. Pharmacokinetics analysis from firs source ↗
May 15, 2024 NIH award 1R44AI181347-01A1 FY2024: $1,024,942 awarded for that fiscal year; activity R44 (SBIR); PI HUTCHINS, JEFF T; recipient as written: INHALON BIOPHARMA, INC., Morrisville, NC. IND-enabling development for IN-0 source ↗
May 6, 2024 NIH award 5SB1AI179368-02 FY2024: $996,814 awarded for that fiscal year; activity SB1 (SBIR); PI HUTCHINS, JEFF T; recipient as written: INHALON BIOPHARMA, INC., Morrisville, NC. GMP manufacturing and IND Filing of I source ↗
Mar 1, 2024 NIH award 1R44AI177199-01A1 FY2024: $1,024,986 awarded for that fiscal year; activity R44 (SBIR); PI HUTCHINS, JEFF T; recipient as written: INHALON BIOPHARMA, INC., Morrisville, NC. SBIR: IND-enabling development of source ↗
Jun 27, 2023 NIH award 5R44AI167461-02 FY2023: $1,018,961 awarded for that fiscal year; activity R44 (SBIR); PI HUTCHINS, JEFF T; recipient as written: INHALON BIOPHARMA, INC., Morrisville, NC. IND-enabling development for IN-002 source ↗
May 26, 2023 NIH award 1SB1AI179368-01 FY2023: $999,810 awarded for that fiscal year; activity SB1 (SBIR); PI HUTCHINS, JEFF T; recipient as written: INHALON BIOPHARMA, INC., Morrisville, NC. GMP manufacturing and IND Filing of I source ↗
Jul 12, 2022 NIH award 1R44AI167461-01 FY2022: $1,023,232 awarded for that fiscal year; activity R44 (SBIR); PI HUTCHINS, JEFF T; recipient as written: INHALON BIOPHARMA, INC., Morrisville, NC. IND-enabling development for IN-002 source ↗